Exploration of the Parameters Influencing the Effort Limitation of Patients Suffering From Homozygous Sickle Cell Anemia
PHYSIO-EXDRE
Evaluation of Effort Limitation Parameters of Patients With Homozygous Sickle Cell Disease
1 other identifier
observational
30
1 country
1
Brief Summary
The cardiovascular complications of sickle cell disease are associated with major morbidity and mortality, as well as impaired quality of life. Stratifying the cardiovascular risk of these patients solely on resting parameters (blood pressure, cardiac ultrasound) is limited. The hypothesis that an exhaustive analysis of the physiological parameters of exercise is launched allows more relevant phenotyping and therefore much better stratification of the individual risk of these patients.. Recent studies have shown a paradigm shift in the use of physical activity. Hitherto inadvisable (acidosis, vaso-occlusive crises), if adapted, moderate and regular, it can lead to functional improvement and a reduction in crises. As a result, cardiovascular exercise rehabilitation is becoming increasingly popular in this population. It's easy to see how effort assessment, particularly through cardiorespiratory exchanges, will become more common in this pathology, making its analysis accessible and interesting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2022
CompletedFirst Submitted
Initial submission to the registry
June 27, 2022
CompletedFirst Posted
Study publicly available on registry
December 19, 2024
CompletedDecember 19, 2024
July 1, 2023
1 year
June 27, 2022
December 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
To define different clinico-biological profiles in patients with sickle cell disease (HbSS)
To define different clinico-biological profiles in patients with sickle cell disease (HbSS) by means of an exhaustive physiological analysis coupled with exercise.
4 weeks
Secondary Outcomes (1)
Study resting characteristics to identify at an early stage patients with potential cardiac alterations.
4 weeks
Interventions
Simultaneous performance of an echocardiogram (part of the follow-up assessment for sickle cell heart disease) at rest and then during the cardiorespiratory stress test, and an ear capillary lactatemia analysis (already routinely performed to ensure the safety of the cardiorespiratory stress test) during the cardiorespiratory stress test routinely performed at Mondor University Hospital prior to cardiovascular rehabilitation programs.
Eligibility Criteria
Patients with homozygous sickle cell disease
You may qualify if:
- Adult patient ≥ 18 years old
- Affiliated with a social security scheme (beneficiary or beneficiary's beneficiary)
You may not qualify if:
- Pregnant or breast-feeding women
- Patients under guardianship, curatorship or legal protection
- Patient under AME
- Patient with a contraindication or unsuitability for physical activity on a cycloergometer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux de Paris-Hôpital Henri Mondor
Créteil, Paris, 94010, France
Related Publications (5)
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013 Aug 20;128(8):873-934. doi: 10.1161/CIR.0b013e31829b5b44. Epub 2013 Jul 22. No abstract available.
PMID: 23877260BACKGROUNDhttp://beh.santepubliquefrance.fr/beh/2015/8/2015_8_2.html
BACKGROUNDFitzhugh CD, Lauder N, Jonassaint JC, Telen MJ, Zhao X, Wright EC, Gilliam FR, De Castro LM. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol. 2010 Jan;85(1):36-40. doi: 10.1002/ajh.21569.
PMID: 20029950BACKGROUNDHammoudi N, Lionnet F, Redheuil A, Montalescot G. Cardiovascular manifestations of sickle cell disease. Eur Heart J. 2020 Apr 1;41(13):1365-1373. doi: 10.1093/eurheartj/ehz217.
PMID: 31005979BACKGROUNDGuazzi M, Bandera F, Ozemek C, Systrom D, Arena R. Cardiopulmonary Exercise Testing: What Is its Value? J Am Coll Cardiol. 2017 Sep 26;70(13):1618-1636. doi: 10.1016/j.jacc.2017.08.012.
PMID: 28935040BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Thomas D'HUMIERES, Dr
Henri Mondor University Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 27, 2022
First Posted
December 19, 2024
Study Start
March 10, 2021
Primary Completion
March 10, 2022
Study Completion
March 11, 2022
Last Updated
December 19, 2024
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share
Les données sont la propriété de l'APHP